Colistin sulfate: Full Drug Profile
Colistin sulfate - General Information
Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistin sulfates A, B, and C) which act as detergents on cell membranes. Colistin sulfate is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.
Pharmacology of Colistin sulfate
Colistin sulfate is a polymyxin antibiotic agent. Polymyxins are cationic polypeptides that disrupt the bacterial cell membrane through a detergentlike mechanism. With the development of less toxic agents, such as extended-spectrum penicillins and cephalosporins, parenteral polymyxin use was largely abandoned, except for the treatment of multidrug-resistant pulmonary infections in patients with cystic fibrosis. More recently, however, the emergence of multidrug-resistant gram-negative bacteria, such as Pseudomonas aeruginosa and Acinetobacter baumannii, and the lack of new antimicrobial agents have led to the revived use of the polymyxins.
Additional information about Colistin sulfate
- Colistin sulfate Indication
For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly Pseudomonas aeruginosa.
- Mechanism Of Action
- Colistin sulfate is a surface active agent which penetrates into and disrupts the bacterial cell membrane. Colistin sulfate is polycationic and has both hydrophobic and lipophilic moieties. It interacts with the bacterial cytoplasmic membrane, changing its permeability. This effect is bactericidal. There is also evidence that polymyxins enter the cell and precipitate cytoplasmic components, primarily ribosomes.
- Generic Name
- Colistin
- Drug Category
- Anti-Bacterial Agents
- Drug Type
- Small Molecule; Approved
- Other Brand Names containing Colistin
- Colistin sulfate; Colistin sulfate, nonsterile; Colistin sulphate; Coly-mycin S; Polymyxin E sulfate; Polymyxin E. Sulfate;
- Absorption
- Very poor absorption from gastrointestinal tract.
- Toxicity (Overdose)
- Oral LD50 in rats is 5450 mg/kg. Overdosage with colistimethate can cause neuromuscular blockade characterized by paresthesia, lethargy, confusion, dizziness, ataxia, nystagmus, disorders of speech and apnea. Respiratory muscle paralysis may lead to apnea, respiratory arrest and death.
- Half Life
- 5 hours
- Dosage Forms of Colistin sulfate
- Powder, for solution Intravenous
- Chemical IUPAC Name
- N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-(1-hydroxyethyl)-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-5-methylheptanamide
- Chemical Formula
- C52H98N16O13
- Colistin on Wikipedia
- https://en.wikipedia.org/wiki/Colistin
- Organisms Affected
- Gram-negative bacilli
